Curcumin Nanoparticles as Promising Therapeutic Agents for Drug Targets
Curcuma longa is very well-known medicinal plant not only in the Asian hemisphere but also known across the globe for its therapeutic and medicinal benefits. The active moiety of Curcuma longa is curcumin and has gained importance in various treatments of various disorders such as antibacterial, antiprotozoal, cancer, obesity, diabetics and wound healing applications. Several techniques had been exploited as reported by researchers for increasing the therapeutic potential and its pharmacological activity. Here, the dictum is the new room for the development of physicochemical, as well as biological, studies for the efficacy in target specificity. Here, we discussed nanoformulation techniques, which lend support to upgrade the characters to the curcumin such as enhancing bioavailability, increasing solubility, modifying metabolisms, and target specificity, prolonged circulation, enhanced permeation. Our manuscript tried to seek the attention of the researcher by framing some solutions of some existing troubleshoots of this bioactive component for enhanced applications and making the formulations feasible at an industrial production scale. This manuscript focuses on recent inventions as well, which can further be implemented at the community level.
Top-30
Journals
|
2
4
6
8
10
12
14
|
|
|
ACS Symposium Series
13 publications, 7.69%
|
|
|
Pharmaceutics
5 publications, 2.96%
|
|
|
Molecules
4 publications, 2.37%
|
|
|
Environmental Science and Pollution Research
4 publications, 2.37%
|
|
|
Polymers
3 publications, 1.78%
|
|
|
Pharmaceuticals
3 publications, 1.78%
|
|
|
Antioxidants
3 publications, 1.78%
|
|
|
Frontiers in Pharmacology
3 publications, 1.78%
|
|
|
Journal of Drug Delivery Science and Technology
3 publications, 1.78%
|
|
|
Current Nanomedicine
2 publications, 1.18%
|
|
|
Frontiers in Aging Neuroscience
2 publications, 1.18%
|
|
|
International Journal of Biological Macromolecules
2 publications, 1.18%
|
|
|
Gels
2 publications, 1.18%
|
|
|
Molecular Biology Reports
2 publications, 1.18%
|
|
|
Pharmaceutical Nanotechnology
2 publications, 1.18%
|
|
|
Reference Series in Phytochemistry
2 publications, 1.18%
|
|
|
Cancers
2 publications, 1.18%
|
|
|
Drug Delivery and Translational Research
2 publications, 1.18%
|
|
|
Metabolic Brain Disease
2 publications, 1.18%
|
|
|
Current Pharmaceutical Design
2 publications, 1.18%
|
|
|
Discover Nano
2 publications, 1.18%
|
|
|
Zeitschrift fur Naturforschung - Section C Journal of Biosciences
2 publications, 1.18%
|
|
|
Carbohydrate Research
2 publications, 1.18%
|
|
|
Materials
1 publication, 0.59%
|
|
|
Frontiers in Bioengineering and Biotechnology
1 publication, 0.59%
|
|
|
Frontiers in Oncology
1 publication, 0.59%
|
|
|
Frontiers in Cell and Developmental Biology
1 publication, 0.59%
|
|
|
Aquaculture International
1 publication, 0.59%
|
|
|
International Journal of Surgery
1 publication, 0.59%
|
|
|
2
4
6
8
10
12
14
|
Publishers
|
5
10
15
20
25
30
35
|
|
|
Springer Nature
33 publications, 19.53%
|
|
|
MDPI
29 publications, 17.16%
|
|
|
Elsevier
28 publications, 16.57%
|
|
|
Bentham Science Publishers Ltd.
16 publications, 9.47%
|
|
|
American Chemical Society (ACS)
16 publications, 9.47%
|
|
|
Wiley
14 publications, 8.28%
|
|
|
Frontiers Media S.A.
10 publications, 5.92%
|
|
|
Taylor & Francis
7 publications, 4.14%
|
|
|
Institute of Electrical and Electronics Engineers (IEEE)
3 publications, 1.78%
|
|
|
Hindawi Limited
2 publications, 1.18%
|
|
|
Walter de Gruyter
2 publications, 1.18%
|
|
|
F1000 Research
1 publication, 0.59%
|
|
|
Chinese Physiology Society/Chung-kuo Sheng Li Hsueh Hui
1 publication, 0.59%
|
|
|
Medknow
1 publication, 0.59%
|
|
|
IntechOpen
1 publication, 0.59%
|
|
|
A and V Publications
1 publication, 0.59%
|
|
|
ifmbe proceedings
1 publication, 0.59%
|
|
|
AIP Publishing
1 publication, 0.59%
|
|
|
CABI Publishing
1 publication, 0.59%
|
|
|
5
10
15
20
25
30
35
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.